Experimental Nutrient Kit May Avert Postpartum Depression

This article originally appeared here.
Share this content:
Experimental Nutrient Kit May Avert Postpartum Depression
Experimental Nutrient Kit May Avert Postpartum Depression

TUESDAY, March 14, 2017 (HealthDay News) -- Researchers suggest that three days of an experimental dietary supplementation may eliminate depressed mood after childbirth, according to a study published online March 13 in the Proceedings of the National Academy of Sciences.

Jeffrey Meyer, M.D., Ph.D., a professor of psychiatry at the University of Toronto and co-creator of the product, and colleagues developed a dietary kit to be taken in the first three to five days after childbirth. The ingredients included blueberry juice and blueberry extract and the amino acids tryptophan and tyrosine. To test the product, the researchers assigned 21 healthy new mothers to receive the supplementation for three days, and compared them with 20 new mothers in the control group. The mothers' average age was 32 years.

The researchers found that on day five after childbirth -- when sadness tends to peak -- those who took the supplements scored better on tests of mood. Also, women in the control group showed "robust" signs of depressed mood, while those in the supplement group did not.

"This dietary supplement designed to counter functions of elevated monoamine oxidase activity eliminates vulnerability to depressed mood during the peak of postpartum blues," the authors write.

Meyer is developing natural health products to treat high-risk states for major depressive episode, and is listed as the inventor on a patent application for this dietary supplement.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »